Additional file 1: Table S1. of Quality of life effects of androgen deprivation therapy in a prostate cancer cohort in New Zealand: can we minimize effects using a stratification based on the aldo-keto reductase family 1, member C3 rs12529 gene polymorphism?

Alice Wang (386481); Benji Benjamin (3450491); Dug Han (3450479); Jonathan Masters (3450470); Justin Keogh (3404525); Katja Lange (3450476); Lynnette Ferguson (3450467); Megan Goudie (3450482); Michael Holmes (1490563); Nishi Karunasinghe (3450473); Shuotun Zhu (586065); Stephanie Ellett (3450485); Yifei Zhu (3450488)

Additional file 1: Table S1. of Quality of life effects of androgen deprivation therapy in a prostate cancer cohort in New Zealand: can we minimize effects using a stratification based on the aldo-keto reductase family 1, member C3 rs12529 gene polymorphism?

Authors: Alice Wang (386481)
Benji Benjamin (3450491)
Dug Han (3450479)
Jonathan Masters (3450470)
Justin Keogh (3404525)
Katja Lange (3450476)
Lynnette Ferguson (3450467)
Megan Goudie (3450482)
Michael Holmes (1490563)
Nishi Karunasinghe (3450473)
Shuotun Zhu (586065)
Stephanie Ellett (3450485)
Yifei Zhu (3450488)
Publication date
Publisher
Doi

Abstract

Summary of details related to batch genotyping for the AKR1C3 rs12529 SNP. Description of data-Details provided as a requirement of the Standard Strengthening the Reporting of Genetic Association Studies (STREGA)âAn Extension of the STROBE Statement. (DOCX 62 kb

Similar works

Full text

Available Versions

FigShare

oai:figshare.com:article/43549...

Last time updated on 12/02/2018